ARCHIVES

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.

September 15, 2006

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Graalman Objects To Criticism On Contract Competition

April 22, 1977

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995